(Q48891234)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Mutated IDH1 is a favorable prognostic factor for type 2 gliomatosis cerebri (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

12

Yeon-Lim Suh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Mi Jung Kwon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sung Tae Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Mi Jeong Kwon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Doo-Sik Kong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Dageun Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sanghui Park

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

So Young Kang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ji-Young Song

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Do-Hyun Nam

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yoon-La Choi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

14 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

307-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

Heterogeneity maintenance in glioblastoma: a social network

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Gliomatosis cerebri, imaging findings of 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Gliomatosis cerebri presenting as intractable epilepsy during early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Clonal analysis of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Initial chemotherapy in gliomatosis cerebri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Temozolomide in malignant gliomas: current use and future targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

Cancer-associated IDH mutations: biomarker and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00532.X

10.1111/J.1750-3639.2011.00532.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929658%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference